Dalian BIO-CHEM (603360) Fundamentals 2026 — P/E 47.4x, Revenue Analysis | SniperIQ
Dalian BIO-CHEM (603360) is a CN-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥8.5B, trading at ¥12.00 on the SHH. This SniperIQ fundamentals page covers Dalian BIO-CHEM's valuation (P/E 47.4x, P/B 5.6x), profitability (net margin 11.7%), revenue (¥1.7B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Dalian BIO-CHEM's market cap?
Dalian BIO-CHEM (603360) has a market capitalization of approximately ¥8.5B, trading at ¥12.00 on the SHH. Market cap moves with the live share price.
What is Dalian BIO-CHEM's P/E ratio?
Dalian BIO-CHEM's trailing twelve-month P/E ratio is 47.4x, with a price-to-book (P/B) of 5.6x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.
How profitable is Dalian BIO-CHEM?
Dalian BIO-CHEM runs a net profit margin of 11.7%, a gross margin of 37.0%, and an operating margin of 19.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Dalian BIO-CHEM generate?
Dalian BIO-CHEM reported revenue of ¥1.7B for fiscal year 2025, with net income of ¥210M and earnings per share (EPS) of 0.3. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Dalian BIO-CHEM pay a dividend?
Dalian BIO-CHEM does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Dalian BIO-CHEM financially healthy?
Dalian BIO-CHEM carries a debt-to-equity ratio of 0.82x and a current ratio of 2.86x, with a market beta of 0.12. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Dalian BIO-CHEM a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dalian BIO-CHEM (603360) the key facts are: market cap ¥8.5B, P/E 47.4x, revenue ¥1.7B, 52-week range 11.18-38.98. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.
Track Dalian BIO-CHEM's full fundamentals live
Get Dalian BIO-CHEM's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.